Board Members and Executive Officers
Directors
-
Hiroshi Nomura
Representative Director, President and CEO
Career
-
April 1981
Joined Sumitomo Chemical Co., Ltd.
-
January 2008
Joined the Company
-
June 2008
Executive Officer of the Company
-
June 2012
Member of the Board of Directors and Executive Officer of the Company
-
April 2014
Member of the Board of Directors and Managing Executive Officer of the Company
-
April 2016
Member of the Board of Directors and Senior Managing Executive Officer of the Company
-
April 2017
Representative Director and Senior Managing Executive Officer of the Company
-
April 2018
Representative Director and President and Chief Executive Officer of the Company (to the present)
-
-
Toru Kimura
Representative Director, Senior Managing Executive Officer
Global Corporate Strategy; Global Finance;
Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center;
Regenerative & Cellular Medicine Manufacturing PlantCareer
-
April 1989
Joined Sumitomo Chemical Co., Ltd.
-
October 1992
Joined the former Sumitomo Pharmaceuticals Co., Ltd.
-
April 2012
Vice President, Head of Global Strategy of the Company
-
September 2013
Vice President, Head of the Regenerative & Cellular Medicine Office of the Company
-
April 2015
Executive Officer of the Company
-
June 2016
Member of the Board of Directors and Executive Officer of the Company
-
April 2019
Member of the Board of Directors and Managing Executive Officer of the Company
-
April 2021
Representative Director and Senior Managing Executive Officer of the Company (to the present)
-
-
Yoshiharu Ikeda
Member, Board of Directors, Managing Executive Officer
Drug Research Division
Head of Japan Business UnitCareer
-
April 1985
Joined the former Sumitomo Pharmaceuticals Co., Ltd.
-
June 2010
Executive Officer of the Company
-
January 2012
Executive Vice President of Sunovion Pharmaceuticals Inc.
-
April 2016
Managing Executive Officer of the Company
-
June 2020
Member of the Board of Directors and Managing Executive Officer of the Company (to the present)
-
-
Hiroyuki Baba
Member, Board of Directors, Managing Executive Officer
Global Data Design Office; Legal Affairs; Intellectual Property;
IT Management & Digital Transformation;
Frontier Business OfficeCareer
-
April 1982
Joined Sumitomo Chemical Co., Ltd.
-
April 2013
Executive Vice President of Sunovion Pharmaceuticals Inc.
-
April 2014
Joined the Company
-
April 2014
Executive Officer of the Company
-
April 2019
Managing Executive Officer of the Company
-
June 2022
Member of the Board of Directors and Managing Executive Officer of the Company (to the present)
-
-
Shigeyuki Nishinaka
Member, Board of Directors, Managing Executive Officer
Business Development & ManagementCareer
-
April 1989
Joined NKK Corporation (currently JFE Holdings, Inc.)
-
October 1994
Joined the former Sumitomo Pharmaceuticals Co., Ltd.
-
August 2001
Joined Daiichi Pharmaceutical Co., Ltd. (currently Daiichi Sankyo Co., Ltd.)
-
February 2009
Joined the Company
-
January 2014
Vice President, Head of Global Oncology Office of the Company
-
April 2014
Administration Officer of the Company
-
April 2017
Executive Officer of the Company
-
April 2020
Managing Executive Officer of the Company
-
June 2022
Member of the Board of Directors and Managing Executive Officer of the Company (to the present)
-
-
Saeko Arai
Member, Board of Directors (Outside)
Career
-
November 2002
President of Gratia, Inc. (currently, Acuray, Inc.) (to the present)
-
June 2018
Member of the Board of Directors of the Company (to the present)
-
June 2018
Outside Director of Tokyu Fudosan Holdings Corporation (to the present)
-
April 2019
Professor at the Faculty of Business Administration of Hakuoh University (to the present)
-
-
Nobuhiro Endo
Member, Board of Directors (Outside)
Career
-
April 2010
President (Representative Director) of NEC Corporation
-
June 2018
Outside Director of Japan Exchange Group, Inc. (to the present)
-
June 2019
Member of the Board of Directors of the Company (to the present)
-
June 2019
Chairman of the Board of NEC Corporation
-
June 2019
Outside Director of Tokyo Marine Holdings, Inc. (to the present)
-
June 2022
Executive Advisor of NEC Corporation (to the present)
-
June 2022
Outside Director of Nisshin Seifun Group Inc. (to the present)
-
-
Minoru Usui
Member, Board of Directors (Outside)
Career
-
June 2008
President and Representative Director of Seiko Epson Corporation, Chief Executive Officer of Seiko Epson Corporation
-
April 2020
Chairman and Director of Seiko Epson Corporation (to the present)
-
June 2021
Member of the Board of Directors of the Company (to the present)
-
June 2021
Outside Director of IHI Corporation (to the present)
-
-
Koji Fujimoto
Member, Board of Directors (Outside)
Career
-
April 1987
Joined the Ministry of International Trade and Industry (MITI)
(currently the Ministry of Economy, Trade and Industry (METI)) -
July 2008
Director, Service Industries Division of METI (Director, Healthcare Industries Division after organizational revision in July 2011)
-
July 2015
Councillor, Cabinet Secretariat (Assistant Director, Office of Healthcare Policy)
-
August 2019
Specially Appointed Professor, Tokyo Medical and Dental University (to the present)
-
August 2019
Senior URA, Research University Promotion Organization, Tokyo Medical and Dental University
-
August 2019
Deputy Director, Research Center for Industry Alliances, Tokyo Medical and Dental University
-
June 2022
Member of the Board of Directors of the Company (to the present)
-
March 2023
Deputy Director / Senior URA, Open Innovation Center, Institute of Research Innovation, Tokyo Medical and Dental University (to the present)
-
March 2023
Director, Emergency Assistance Japan Co., Ltd. (to the present)
-
Audit & Supervisory Board Members
-
Takashi Kutsunai
Audit & Supervisory Board Member
Career
-
April 1981
Joined Sumitomo Chemical Co., Ltd.
-
October 1984
Joined the former Sumitomo Pharmaceuticals Co., Ltd.
-
April 2012
Vice President, Head of Internal Auditing of the Company
-
April 2013
Administration Officer of the Company
-
June 2018
Full-time Audit & Supervisory Board Member of the Company (to the present)
-
-
Hisayoshi Kashima
Audit & Supervisory Board Member
Career
-
April 1985
Joined the former Sumitomo Pharmaceuticals Co., Ltd.
-
June 2007
Vice President, Head of Finance & Accounting of the Company
-
April 2012
Member, Board of Directors of Sumitomo Pharmaceuticals (Suzhou) Co., Ltd. (currently Sumitomo Pharma (Suzhou) Co., Ltd.)
-
April 2014
Vice President, Head of Finance & Accounting of the Company
-
June 2023
Full-time Audit & Supervisory Board Member of the Company (to the present)
-
-
Yoshio Iteya
Audit & Supervisory Board Member (Outside)
Career
-
January 1992
Partner at Mori Hamada & Matsumoto
-
April 2004
Specially Appointed Professor at Hitotsubashi University School of Law (to the present)
-
June 2018
Audit & Supervisory Board Member of the Company (to the present)
-
January 2021
Partner at Anderson Mori & Tomotsune (to the present)
-
-
Mayumi Mochizuki
Audit & Supervisory Board Member (Outside)
Career
-
April 2019
Professor Emeritus at Keio University (to the present)
-
April 2019
Project Professor at the Faculty of Pharmacy of Keio University
-
April 2019
Adviser of the International Medical Information Center (to the present)
-
April 2020
Special Adviser of the International University of Health and Welfare (to the present)
-
October 2020
Vice President of Science Council of Japan (to the present)
-
June 2021
Audit & Supervisory Board Member of the Company (to the present)
-
-
Daishiro Michimori
Audit & Supervisory Board Member (Outside)
Career
-
April 1979
Joined the Ministry of Finance
-
October 2010
Councillor, the Cabinet Secretariat (National Policy Unit)
-
August 2012
Regional Commissioner, the Tokyo Regional Taxation Bureau
-
April 2016
Advisor Attorney, TMI Associates
-
June 2016
Outside Member of the Board, World Co., Ltd.
-
April 2018
Senior Managing Director, Daiwa Institute of Research Ltd.
-
April 2021
Visiting Lawyer, Shimada Hamba & Osajima (up to the present)
-
April 2022
Senior Advisor, Daiwa Institute of Research Ltd.
-
June 2022
Audit & Supervisory Board Member of the Company (to the present)
-
Executive Officers
-
Hideyuki Harada
Managing Executive Officer
Technology Research & Development Division;
Manufacturing Division
Deputy Head of Japan Business Unit -
Atsuko Higuchi
Managing Executive Officer
External Affairs; Corporate Secretariat; Human Resources -
Takuya Taguchi
Managing Executive Officer
Sales & Marketing Division
Senior Vice President, Head of Sales & Marketing Division
Deputy Head of Japan Business Unit -
Koichi Kozuki
Executive Officer
Regulatory Affairs; Medical Science; Corporate Regulatory Compliance & Quality Assurance
Senior Vice President, Head of Corporate Regulatory Compliance & Quality Assurance Division
Deputy Head of Japan Business Unit -
Isao Shimizu
Executive Officer
Senior Vice President, Head of Drug Research Division
Senior Executive Research Director -
Yumi Sato
Executive Officer
Drug Development Division
Senior Vice President, Head of Drug Development Division
CNS Strategic Alliance, Sumitomo Pharma America, Inc. -
Kenji Ueno
Executive Officer
Senior Vice President, Head of Technology Research & Development Division -
Naoki Noguchi
Executive Officer
Corporate Governance; Corporate Communications
Vice President, Head of Corporate Communications -
Tsutomu Nakagawa
Executive Officer
Chief Strategy Officer, Sumitomo Pharma America, Inc. -
Myrtle Potter
Executive Officer
President and CEO, Sumitomo Pharma America, Inc. -
Adele Gulfo
Executive Officer
CEO of Biopharma Commercial Unit, Sumitomo Pharma America, Inc. -
Armin Szegedi
Executive Officer
Chief Medical Officer, Sumitomo Pharma America, Inc.